Advertisement

Perrigo Company plc PRGO

Set alert

Price alert · PRGO

All alert types
15.78 USD -0.12 -0.75%

At close · Oct 30

15.78 0.00 0.00%

After hours · Oct 30, 4:01 PM ET

Bid
15.73 × 300
Ask
15.80 × 2,000
15.42 Day range 16.14
9.25 52-week range 20.74
YTD
+13.36%
1 year
-23.55%
Open
16.07
Prev close
15.90
Mkt cap
2.19B
Vol
3.35M
Avg vol
2.71M
EPS
-12.28
P/E
0.00
Div yield
7.30%
More statistics
Low
15.42
High
16.14
Forward P/E
6.61
Beta
0.69
Short ratio
8.12
Inst. own
115.75%
Dividend
1.16
Ex-div date
Aug 27, 2026
Earnings
Nov 4, 2026
50-d avg
14.78
200-d avg
12.44
1y target
16.50

2Y chart

Chart tools
Interval

Events in this range
  • Nov 29, 2024Dividend: 0.276
  • Mar 7, 2025Dividend: 0.29
  • May 30, 2025Dividend: 0.29
  • Aug 6, 2025Earnings: 0.57; estimate 0.59; surprise -3.39%
  • Aug 7, 2025Rating: Canaccord Genuity · Buy → Buy
  • Aug 29, 2025Dividend: 0.29
  • Oct 27, 2025Rating: Jefferies · Hold → Hold
  • Nov 5, 2025Earnings: 0.8; estimate 0.75; surprise 6.67%
  • Nov 6, 2025Downgrade: JP Morgan · Overweight → Neutral
  • Nov 6, 2025Rating: Canaccord Genuity · Buy → Buy
  • Nov 28, 2025Dividend: 0.29
  • Dec 15, 2025Rating: JP Morgan · Neutral → Neutral
  • Feb 26, 2026Earnings: 0.77; estimate 0.8; surprise -3.75%
  • Feb 27, 2026Rating: Canaccord Genuity · Buy → Buy
  • Mar 2, 2026Dividend: 0.29
  • May 6, 2026Earnings: 0.43; estimate 0.39; surprise 10.26%
  • May 29, 2026Dividend: 0.29
  • Aug 5, 2026Earnings: 0.5; estimate 0.388; surprise 28.87%
  • Aug 28, 2026Dividend: 0.29
Signals (81)
NameDateAgo
MACD: Sell SignalOct 27, 20264 days ago
RSI: OverboughtOct 16, 20262 weeks ago
MACD: Buy SignalOct 12, 20262 weeks ago
MACD: Sell SignalOct 1, 20261 month ago
MACD: Buy SignalSep 25, 20261 month ago
MACD: Sell SignalSep 2, 20261 month ago
RSI: OverboughtAug 31, 20262 months ago
RSI: OverboughtAug 21, 20262 months ago
RSI: OverboughtAug 19, 20262 months ago
SMA: BullishAug 7, 20262 months ago
SMA: BearishAug 6, 20262 months ago
SMA: BullishAug 5, 20262 months ago
RSI: OverboughtAug 5, 20262 months ago
SMA: BullishAug 3, 20262 months ago
MACD: Buy SignalAug 3, 20262 months ago
MACD: Sell SignalJul 24, 20263 months ago
SMA: BearishJul 17, 20263 months ago
SMA: BullishJul 16, 20263 months ago
MACD: Buy SignalJul 16, 20263 months ago
MACD: Sell SignalJul 14, 20263 months ago
SMA: BearishJul 8, 20263 months ago
SMA: BullishJul 2, 20264 months ago
MACD: Buy SignalJul 1, 20264 months ago
MACD: Sell SignalJun 16, 20264 months ago
SMA: BullishJun 8, 20264 months ago
MACD: Buy SignalJun 8, 20264 months ago
SMA: BearishJun 1, 20265 months ago
MACD: Sell SignalJun 1, 20265 months ago
MACD: Buy SignalMay 28, 20265 months ago
SMA: BullishMay 27, 20265 months ago
SMA: BearishMay 26, 20265 months ago
SMA: BullishMay 20, 20265 months ago
SMA: BearishMay 15, 20265 months ago
MACD: Sell SignalMay 11, 20265 months ago
SMA: BullishApr 30, 20266 months ago
SMA: BearishApr 29, 20266 months ago
SMA: BullishApr 17, 20266 months ago
MACD: Buy SignalMar 24, 20267 months ago
RSI: OversoldMar 18, 20267 months ago
RSI: OversoldMar 2, 20268 months ago
SMA: BearishFeb 26, 20268 months ago
MACD: Sell SignalFeb 26, 20268 months ago
MACD: Buy SignalFeb 13, 20268 months ago
MACD: Sell SignalFeb 12, 20268 months ago
MACD: Buy SignalFeb 11, 20268 months ago
SMA: BullishJan 30, 20269 months ago
SMA: BearishJan 29, 20269 months ago
MACD: Sell SignalJan 26, 20269 months ago
SMA: BullishJan 8, 20269 months ago
MACD: Buy SignalNov 26, 202511 months ago
RSI: OversoldNov 5, 202512 months ago
MACD: Sell SignalOct 30, 20251 year ago
MACD: Buy SignalSep 26, 20251 year ago
RSI: OversoldSep 22, 20251 year ago
RSI: OversoldSep 16, 20251 year ago
MACD: Sell SignalSep 9, 20251 year ago
MACD: Buy SignalAug 22, 20251 year ago
RSI: OversoldAug 6, 20251 year ago
SMA: BearishJul 31, 20251 year ago
MACD: Sell SignalJul 31, 20251 year ago
MACD: Buy SignalJul 23, 20251 year ago
MACD: Sell SignalJul 17, 20251 year ago
MACD: Buy SignalJul 1, 20251 year ago
MACD: Sell SignalJun 16, 20251 year ago
MACD: Buy SignalJun 11, 20251 year ago
SMA: BullishJun 6, 20251 year ago
SMA: BearishJun 5, 20251 year ago
MACD: Sell SignalJun 3, 20251 year ago
SMA: BullishMay 16, 20251 year ago
SMA: BearishMay 13, 20251 year ago
SMA: BullishMay 8, 20251 year ago
MACD: Buy SignalApr 28, 20251 year ago
SMA: BearishApr 4, 20251 year ago
MACD: Sell SignalMar 13, 20251 year ago
SMA: BullishFeb 28, 20251 year ago
RSI: OverboughtFeb 28, 20251 year ago
SMA: BearishFeb 26, 20251 year ago
SMA: BullishFeb 21, 20251 year ago
MACD: Buy SignalJan 23, 20251 year ago
RSI: OversoldJan 14, 20251 year ago
RSI: OverboughtNov 27, 20241 year ago

Key statistics

Market cap
2.19B
Enterprise value
5.28B
Trailing P/E
0.00
Forward P/E
6.61
PEG ratio
1.14
Price / sales
0.53
Price / book
0.87
EPS (TTM)
-12.28
Beta
0.69
Dividend yield
7.30%
Payout ratio
1348.75%
Profit margin
-41.85%
Revenue (TTM)
4.14B
Revenue growth
-3.20%
Free cash flow
437.21M
Total cash
399.70M
Total debt
3.48B
Return on equity
-48.75%
Shares outstanding
138.77M
Short % of float
26.72%
50-day average
14.78
200-day average
12.44

Analyst view

Consensus: hold

Hold
Price target (mean) 16.50 +4.6% upside
Target (low)
14.00
Target (mean)
16.50
Target (high)
20.00
Ratings (0m) 5 1 buy · 4 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold4
  • Sell0
  • Strong sell0

Next earnings

Nov 4, 2026

Expected Nov 4, 2026. Consensus EPS estimate 0.51784.

Earnings history

Financials — quick view

All financials
PRGO Revenue — quarterly 1.02B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
PRGO Net income — quarterly 74.50M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
PRGO EPS — quarterly 0.54
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

PRGO recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2026Sep 27, 20260.511———
Aug 5, 2026Jun 27, 20260.3880.50+0.11+28.87%
May 6, 2026Mar 28, 20260.390.43+0.04+10.26%
Feb 26, 2026Dec 31, 20250.800.77-0.03-3.75%
Nov 5, 2025Sep 27, 20250.750.80+0.05+6.67%
Aug 6, 2025Jun 28, 20250.590.57-0.02-3.39%

Upgrades / downgrades

PRGO analyst upgrades and downgrades
DateFirmActionFromTo
Feb 27, 2026Canaccord GenuitymainBuyBuy
Dec 15, 2025JP MorganmainNeutralNeutral
Nov 6, 2025Canaccord GenuitymainBuyBuy
Nov 6, 2025JP MorgandownOverweightNeutral
Oct 27, 2025JefferiesmainHoldHold
Aug 7, 2025Canaccord GenuitymainBuyBuy

About Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Ireland
Website
perrigo.com

News

Your note

Sign in to keep a note on PRGO — it syncs with the Stock Master app.

Insider holders

PRGO insider holders
InsiderRelationLatest transactionDateShares held
ALFORD BRADLEY ADirectorConversion of Exercise of derivative securitySep 10, 202646,121
ASHFORD ORLANDO DDirectorConversion of Exercise of derivative securityMay 13, 202627,717
BEZERRA EDUARDO GUARITAChief Financial OfficerConversion of Exercise of derivative securityJun 4, 202684,700
JANISH RONALD CRAIGChief Technology OfficerConversion of Exercise of derivative securityApr 3, 202535,558
KARABOUTIS ADRIANADirectorConversion of Exercise of derivative securityMay 13, 202527,629
LOCKWOOD-TAYLOR PATRICKFormerConversion of Exercise of derivative securityJun 4, 2026123,170

Institution ownership

PRGO institution ownership
Holder% heldSharesValueReported
Blackrock Inc.16.36%22,703,127358.03MJun 29, 2026
Neuberger Berman Group, LLC7.70%10,680,100168.43MJun 29, 2026
Vanguard Portfolio Management LLC6.52%9,045,661142.65MJun 29, 2026
Price (T.Rowe) Associates Inc6.27%8,700,421137.21MJun 29, 2026
State Street Corporation6.15%8,528,704134.50MJun 29, 2026
Fuller & Thaler Asset Management Inc.5.40%7,498,227118.25MJun 29, 2026

Fund ownership

PRGO fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.95%8,259,312130.25MSep 29, 2026
UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd.4.26%5,906,43693.14MJun 29, 2026
T. Rowe Price Mid-Cap Value Fund, Inc.3.27%4,541,19071.61MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.17%4,399,26169.38MJun 29, 2026
Invesco Exch-Trd Fd. TRT-Invesco High Yield Eqy. Dividend Achievers ET2.76%3,823,39760.29MAug 30, 2026
iShares Trust-iShares Russell 2000 ETF2.63%3,644,90957.48MSep 29, 2026
Advertisement